Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|9|2|101-109

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.9, Iss.2, 2014-08, pp. : 101-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 9, Iss. 2, 2014-08 ,pp. : 76-84

Bentham Science Publishers

Access to resources Recommend Favorite

Transglutaminase Activity as a Possible Therapeutical Target in Neurodegenerative Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 3, 2013-01 ,pp. : 235-242

Bentham Science Publishers

Access to resources Recommend Favorite

Transglutaminase Inhibition as a Possible Therapeutical Approach to Protect Cells from Death in Neurodegenerative Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 2, 2013-08 ,pp. : 161-168

Bentham Science Publishers

Access to resources Recommend Favorite

Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases

By  

Recent Patents on CNS Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 195-202

Bentham Science Publishers

Access to resources Recommend Favorite

4-Hydroxynonenal and neurodegenerative diseases

By Zarkovic K.  

Molecular Aspects of Medicine, Vol. 24, Iss. 4, 2003-08 ,pp. : 293-303

Elsevier

Access to resources Recommend Favorite